Cost-Effectiveness In The Second-Line Treatment Of Non-Small Cell Lung Cancer (Nsclc) In The Us
Nov 1, 2015, 00:00 AM
10.1016/j.jval.2015.09.1174
https://www.valueinhealthjournal.com/article/S1098-3015(15)03250-7/fulltext
Section Title :
Research Podium Presentations - Session 1 and Session 2
Section Order :
674
First Page :
A457
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03250-7&doi=10.1016/j.jval.2015.09.1174